<DOC>
	<DOCNO>NCT01817309</DOCNO>
	<brief_summary>Peritoneal dialysis ( PD ) first-line treatment end stage renal disease ( ESRD ) Hong Kong . Despite advance antibiotic therapy connecting system , recurrent peritonitis remain major cause peritoneal failure . A reliable predictor relapse peritonitis invaluable management PD peritonitis . Recent study show bacterial-derived lipopolysaccharide ( LPS ) fragment present clinically used fluid dialysis fluid . LPS think derive microorganism inhabit body fluid . The investigator hypothesize presence LPS PD effluent predictor relapse peritonitis PD patient . The investigator plan study 300 patient PD peritonitis . After inform consent , specimens PD effluent collect day initiate antibiotic treatment , every 5 day day complete antibiotic treatment , 28 day later test LPS level . All patient follow one year completion antibiotic therapy development relapsing , recurrent , repeat peritonitis episode . Our study would explore use detect LPS PD effluent non-invasive test prediction relapse peritonitis .</brief_summary>
	<brief_title>Bacteria Endotoxin Peritoneal Dialysis Effluent Predictor Relapsing , Recurrent , Repeat Peritonitis</brief_title>
	<detailed_description />
	<mesh_term>Peritonitis</mesh_term>
	<criteria>least two following : 1. abdominal pain cloudy PD effluent ; 2. leukocytosis PD effluent ( WBC &gt; 100/ml ) ; 3. positive Gramstain culture PD effluent mycobacterial peritonitis obvious surgical problem require laparotomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>renal failure</keyword>
	<keyword>survival</keyword>
	<keyword>peritoneal failure</keyword>
</DOC>